These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26037048)

  • 1. The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.
    Cichocki F; Verneris MR; Cooley S; Bachanova V; Brunstein CG; Blazar BR; Wagner J; Schlums H; Bryceson YT; Weisdorf DJ; Miller JS
    Curr Top Microbiol Immunol; 2016; 395():225-43. PubMed ID: 26037048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells and tumor control.
    Cooley S; Weisdorf DS
    Curr Opin Hematol; 2010 Nov; 17(6):514-21. PubMed ID: 20827184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells as a therapeutic tool in mismatched transplantation.
    Ruggeri L; Capanni M; Mancusi A; Aversa F; Martelli MF; Velardi A
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):427-38. PubMed ID: 15498714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant.
    Velardi A; Ruggeri L; Mancusi A
    Curr Opin Hematol; 2012 Jul; 19(4):319-23. PubMed ID: 22555394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.
    Davis ZB; Felices M; Verneris MR; Miller JS
    Cancer J; 2015; 21(6):486-91. PubMed ID: 26588681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation.
    Flierman R; Westerhuis G; Hameetman M; van Duivenvoorde LM; van Hall T; van Laar JM; Fibbe WE; Toes RE
    Blood; 2007 Jun; 109(12):5524-5. PubMed ID: 17554069
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cells in the treatment of high-risk acute leukaemia.
    Locatelli F; Moretta F; Brescia L; Merli P
    Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
    Lister J; Rybka WB; Donnenberg AD; deMagalhaes-Silverman M; Pincus SM; Bloom EJ; Elder EM; Ball ED; Whiteside TL
    Clin Cancer Res; 1995 Jun; 1(6):607-14. PubMed ID: 9816022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers.
    Stern M; Passweg JR; Meyer-Monard S; Esser R; Tonn T; Soerensen J; Paulussen M; Gratwohl A; Klingebiel T; Bader P; Tichelli A; Schwabe D; Koehl U
    Bone Marrow Transplant; 2013 Mar; 48(3):433-8. PubMed ID: 22941380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation.
    Zakrzewski JL; Holland AM; van den Brink MR
    J Mol Med (Berl); 2007 Aug; 85(8):837-43. PubMed ID: 17333096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
    Pietra G; Vitale C; Pende D; Bertaina A; Moretta F; Falco M; Vacca P; Montaldo E; Cantoni C; Mingari MC; Moretta A; Locatelli F; Moretta L
    Cancer Immunol Immunother; 2016 Apr; 65(4):465-76. PubMed ID: 26289090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials.
    Suen WC; Lee WY; Leung KT; Pan XH; Li G
    Cancer Invest; 2018; 36(8):431-457. PubMed ID: 30325244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell alloreactivity 10 years later.
    Velardi A
    Curr Opin Hematol; 2012 Nov; 19(6):421-6. PubMed ID: 22954728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of hematopoietic cells and their clinical use.
    Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
    Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of natural killer cells in hematopoietic stem cell transplantation.
    Tsirigotis PD; Resnick IB; Shapira MY
    Ann Med; 2012 Mar; 44(2):130-45. PubMed ID: 21410396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation.
    Patil S; Schwarer T
    Intern Med J; 2009 Oct; 39(10):639-47. PubMed ID: 19686544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.